Global Health Limited · NSE:MEDANTA

Global Health — Q2 and H1 FY2025 Earnings Presentation

35 slides from Global Health's earnings presentation, Nov 14, 2024

  1. Slide 1: Exchange filing cover letter: Investor Presentation

    November 14 2024 Ref:- GHL/2024-25/EXCH/83 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

  2. Slide 2: Investor Presentation Q2 and H1 FY2025

    GLOBAL HEALTH LIMITED Dedicated to Life INVESTOR PRESENTATION 5 Q2 and H1 FY2025 1

  3. Slide 3: Contents

    Contents 01 Q2 and H1 FY2025 Performance Update 02 Medanta: Poised to Deliver Sustainable Growth 03 About Us 2

  4. Slide 4: Q2 and H1 FY2025 Performance Update

    01 Q2 and H1 FY2025 Performance Update 3

  5. Slide 5: Q2 FY2025 performance summary

    Q2 FY2025 performance summary Delivered highest ever quarterly Revenue and EBITDA INR 9,748 million INR 2,465 million INR 1,308 million Total Income EBITDA and Margins % Margins % PAT and Margin: 25.3% Margin: 13.4% Q2 FY24 Q2 FY24 Q2 FY24 8,647 million 13% 2,336 million Margin: 27.0% 6% 1,252 milli

  6. Slide 6: Q2 FY2025 performance summary

    Q2 FY2025 performance summary Strong growth across key performance indicators Consolidated Total Income of INR 9,748 million, grew by 12.7% y-o-y and 10.4% on q-o-q basis. The growth was driven by a combination of factors including higher patient volumes, increase in bed occupied days and improvemen

  7. Slide 7: Q2 FY2025 business update

    Q2 FY2025 business update Continued focus on strengthening the core Capacity Expansion Enhance Capabilities  118 Total Beds including 92 census beds added  Magnetom Vida MRI System with Paradigm during the quarter Generator and Da Vinci Xi robotic system operationalized at Gurugram in Q2 FY25  66

  8. Slide 8: Q2 FY2025 clinical achievements

    Q2 FY2025 clinical achievements Continuing the legacy of clinical excellence Medanta Gurugram performed its first CAR-T Cell therapy, an advanced cancer treatment that harnesses the power of the patient’s own immune system to fight cancer Medanta Gurugram achieves significant milestone of completing

  9. Slide 9: Key operating metrics: Revenue and profitability

    Key operating metrics: Revenue and profitability Revenue increased by 12.7%, EBITDA grew by 5.5% y-o-y Total Income (INR million) EBITDA (INR million and margin %) +12.7% +5.5% 9,748 8,647 8,830 2,336 2,465 +10.4% 2,082 +18.4% Q2 FY24 Q1 FY25 Q2 FY25 Q2 FY24 Q1 FY25 Q2 FY25 27.0% 23.6% 25.3% Profit

  10. Slide 10: Key operating metrics: Volumes, occupancies, ALOS

    Key operating metrics: Volumes, occupancies, ALOS Occupied bed days increased by 9% y-o-y on the increased bed capacity Average census and occupied beds ALOS (days) +9.1% +0.2% 3.19 3.05 3.20 +10.0% 2,223 2,354 2,446 1,442 1,385 1,573 Q2 FY24 Q1 FY25 Q2 FY25 Q2 FY24 Q1 FY25 Q2 FY25 65% 59% 64% Censu

  11. Slide 11: Key operating metrics: ARPOB and revenue mix

    Key operating metrics: ARPOB and revenue mix ARPOB growth driven by improved realization ARPOB* (INR) IPD Revenue mix by payor category ** +1.9% 61,003 64,035 62,140 61% 57% 57% 24% 25% 25% 4% 9% 2% 10% 4% 10% 4% 4% 4% Q2 FY24 Q1 FY25 Q2 FY25 Q2 FY24 Q1 FY25 Q2 FY25 Cash TPA CGHS/ ECHS/ Indian Railw

  12. Slide 12: Diverse revenue mix

    Diverse revenue1 mix Significant contribution from complex specialties Revenue mix by specialty Q2 FY24 Revenue mix by specialty Q2 FY25 20% 20% 21% 23% 3% 3% 4% 8,983 5% 8,087 INR million INR million 12% 12% 7% 6% 8% 8% 14% 3 12% 3 11% 12% 3 Heart Digestive Cancer Neuro Kidney & Urology Internal Me

  13. Slide 13: Growth seen in both matured and developing hospitals

    Growth seen in both matured and developing hospitals Matured hospitals continues to deliver strong growth Matured hospitals - Over 6 years Developing hospitals - Less than 6 years Total Income (INR million) EBITDA (INR million and margin %) Total Income (INR million) EBITDA (INR million and margin %

  14. Slide 14: Q2 FY2025 performance summary

    Q2 FY2025 performance summary Well capitalized balance sheet to drive future expansion plans and growth Key Highlights INR million FY2023 FY2024 H1 FY2025 Gross Debt 8,422 4,193 3,019 Cash and Cash Equivalents 13,114 11,913 10,205 • Debt repayment of ~ INR 1,174 million during H1 FY2025 Net Debt / (

  15. Slide 15: Medanta Poised to Deliver Sustainable Growth

    Medanta Poised to Deliver Sustainable Growth 02 Values based growth you can be proud of 14

  16. Slide 16: Medanta is well placed to deliver sustainable growth

    Medanta is well placed to deliver sustainable growth… …while maintaining its core values of patient centric care and clinical leadership and quality CONTINUITY OF CARE TECHNOLOGY Extend clinical THOUGHT ADVANCEMENT services outside LEADERSHIP Use technology to hospital and ENHANCE Build on our impro

  17. Slide 17: Noida hospital construction update

    Noida hospital construction update 97% superstructure complete; MEP work in progress. Expected to commence operations in Q1 FY26 • Project situated in sector 50 Noida, close proximity to metro station • Greenfield project, with bed capacity of 550 beds • Construction started in September 2022 • Mech

  18. Slide 18: Pitampura, New Delhi: ~750 bed in partnership with Society

    Pitampura, New Delhi : ~750 bed in partnership with Society Expanding into the high-growth, densely populated micro markets of Northwest and West Delhi Super specialty hospital in North West Delhi • Medanta has signed an Operations and Management Agreement with Society to operate and manage a ~750 b

  19. Slide 19: Medanta to enter Mumbai market with 500+ bed hospital at Oshiwara

    Medanta to enter Mumbai market with a state-of-the-art, 500+ bedded super-specialty hospital at Oshiwara, Mumbai  The Company has bought 8,859 sq.meters of land in Oshiwara from MHADA for an amount of INR 125.11 crores in a public auction  Medanta has paid INR 125.11 crores and executed lease deed

  20. Slide 20: South Delhi and Indore project update

    South Delhi and Indore project update Project delayed due to ongoing challenges Super specialty hospital in South Delhi Asset light hospital partnership in Indore • ~400-bed super specialty hospital in South Delhi • Site identified in prominent location on MR 10 road • DLF and Medanta will contribut

  21. Slide 21: Medanta clinics

    Medanta clinics Clinics to offer Preventive Health Checks, OPD and Diagnostics services closer to home Medanta Clinic at Golf Course Road, Gurugram Medanta Clinic at Ranchi • Clinic situated on Gold Course road • Clinic situated Atal Smriti Vendor Market Kutchery Road, Ranchi • Total area of 19,000

  22. Slide 22: Completing the Medanta Gurugram campus

    Completing the Medanta Gurugram campus Establishing World Class Medical College and Guest House for Out of City Patients Medanta Medical College Medanta Guest House • To ensure continuity of care for our patients, Medanta to • Establish a world-class, future-ready Medical College in construct a serv

  23. Slide 23: On-going expansion projects

    On-going expansion projects Planned bed capacity addition; well positioned to drive near term growth Number of installed beds 750 500 300 400 50 250 100 100 100 3,008 300 5,908 50 3,058 3,558 30- Patna FY25e Noida - Lucknow Patna - FY26e Lucknow Patna Noida South Indore Mumbai Pitampura, Sep-24 Q1 F

  24. Slide 24: Capex plan next 5 years

    Capex plan next 5 years Total capex of INR ~2,800 crores planned for next 5 years for ~2,900 bed addition INR Crores 250 300 600 1,069 3,639 3,089 150 300 500 300 90 80 470 MaintenanceLucknow Patna Existing Noida South Indore Mumbai Pitampura, Medical Guest Total Capex for 3 Asset Delhi- DLF Delhi S

  25. Slide 25: About Us

    03 About Us 24

  26. Slide 26: Medanta was founded to bring a new type of healthcare to India

    Medanta was founded to bring a new type of healthcare to India… … the human side of healthcare Healthcare is never only about science. It is also about the art of medicine – the human connection, putting the patient first, collaboration, the personal acts of empathy and the values that guide our dec

  27. Slide 27: Growth from a single flagship hospital to a network of 5 hospitals

    Growth from a single flagship hospital in Gurgaon… …to a network of 5 high quality hospitals across north India 2025E MEDANTA HOSPITAL 2021 NOIDA JAI PRABHA Plan for 550 beds 2019 MEDANTA SPECIALTY Expected to MEDANTA HOSPITAL begin phase I 2015 HOSPITAL PATNA operations with MEDANTA ABDUR LUCKNOW ~

  28. Slide 28: One of the largest private hospital chains in North and East India

    One of the largest private hospital chains in North and East India Infrastructure and High quality Awards and technology clinical talent accreditations Built to deliver the Full time doctors; National and international most complex care team based care recognition Network of 5 multi- 1,750+ doctors*

  29. Slide 29: From our flagship Medicity campus, we have grown to ~3,008 beds across 5 cities

    From our flagship Medicity campus in Gurgaon, we have grown to ~3,008 beds across 5 cities Largest private hospital beds in operation under one roof in Delhi (NCR), Uttar Pradesh and Bihar GURGAON LUCKNOW PATNA 1,440 beds; 316 ICU beds 751 beds; 202 ICU beds (950 planned) 442 beds; 112 ICU beds (650

  30. Slide 30: Our Mission and Values

    Our Mission and Values Embracing a new era and redefining our purpose Core Values Patient centric care: Foster a culture where every one of us is MISSION committed to care for patients and their caregivers Our mission is to deliver Leadership and quality: Commit to delivering excellence in world cla

  31. Slide 31: The Medanta Model of Care

    The Medanta Model of Care Delivering the highest quality of medicine with care and compassion Exceptional clinical talent What it means for patients and caregivers? • Super specialized doctors provide the highest quality of care through a team based integrated approach Trust based compassionate Worl

  32. Slide 32: Annexure: Profit and Loss statement

    Annexure: Profit and Loss statement Half Year End Quarter Y-o-Y Growth Y-o-Y Growth Q-o-Q Growth INR million H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25 % % % Revenue from operations 16,300 18,176 11.5% 8,504 8,611 9,566 12.5% 11.1% Other income 292 401 37.7% 142 219 182 27.9% (16.9)% Total income 16,59

  33. Slide 33: Annexure: Operational parameters

    Annexure: Operational parameters Half Year End Quarter Y-o-Y Growth Y-o-Y Growth Q-o-Q Growth Key metrics H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25 % % % Total Beds 2,725 3,008 10.4% 2,725 2,890 3,008 10.4% 4.1% Average Census Beds 2,223 2,400 8.0% 2,223 2,354 2,446 10.0% 3.9% Average Occupied Bed Day

  34. Slide 34: Annexure: Abbreviations and Definitions

    Annexure: Abbreviations and Definitions Abbreviations  INR : Indian Rupee  NABH : National Accreditation Board for Hospitals & Healthcare Providers  NABL : National Accreditation Board for Testing and Calibration Laboratories  JCI : Joint Commission International  OPD : Out-Patient Department 

  35. Slide 35: Contact us

    Contact us About Medanta Contact Details Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and Ravi Gothwal – cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest Head of Investor Relations civilian awards in India, a

Global Health — Q2 and H1 FY2025 Earnings Presentation on 6ix